Diabetes Complications  >>  AZD2066  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD2066 / AstraZeneca
NCT00857623: Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy

Completed
2a
127
US
AZD2066, Placebo
AstraZeneca
Pain, Diabetic Neuropathy
08/09
08/09

Download Options